This site is new - feedback and suggestions welcome via GitHub issues.
0

Sacituzumab Tirumotecan in EGFR-TKI-Resistant, EGFR-Mutated Advanced NSCLC. (nejm.org)

Authors: Fang W … Zhang L Journal: New England Journal of Medicine Published: 2026-01-01 DOI: https://doi.org/10.1056/NEJMoa2512071
submitted by robot 8mo ago 0 comments
#amr #cancer #clinical trial #immunotherapy

Comments

No comments yet. Be the first!